METYS PHARMACEUTICALS
Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy-induced peripheral neuropathy, an uncomfortable and troubling side effect of several important cancer treatments. MP-101 is an orally-active modulator of glutamate signalling in spine and brain. Glutamate signalling has long been a sought-after target for the development of new central nervous system drug candidates. MP-101 is a particularly well-suited candidate, with outstanding pharmaceutic properties; it is a smal... l molecule, obtained by a straight-forward chemical manufacturing process. It is also orally active in a wide range of rodent models of central nervous system disorders, such as depression, cognition, or neuropathic pain. MP-101 is a patent-pending non-racemic mixture of the left-handed and right-handed versions (the "enantiomers") of dimiracetam. It is not a one-to-one mixture (a "racemate"), but a ratio that has been chosen because it is - unexpectedly - considerably more potent pharmacologically than the racemate. While the one-to-one mixture has long been known to be superior to either of the two single-handed enantiomers alone, Metys Pharmaceuticals has discovered that certain mixtures of dimiracetam enantiomers are far more potent still. Metys Pharmaceuticals has licensed the world-wide exclusive rights to racemic dimiracetam from Neurotune AG, including the entire dossier of regulatory studies supporting clinical trials of racemic dimiracetam. Metys Pharmaceuticals now aims to use these pharmacological, toxicological and clinical data obtained with racemic dimiracetam to support the future clinical trials of MP-101.
METYS PHARMACEUTICALS
Industry:
Medical Medical Device Pharmaceutical
Founded:
2013-04-23
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.metys-pharma.ch
Total Employee:
1+
Status:
Active
Contact:
+41794087972
Email Addresses:
[email protected]
Total Funding:
1.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Mobile Non Scaleable Content Nginx Google Apps For Business
Similar Organizations
BrachyDOSE
BrachyDOSE is a cancer treatment quality control tool to help oncologists to reach best possible treatment results.
Kamedi GmbH
Kamedi is providing innovative medical devices for a great outdoor experience
Mater Dyamics
Mater Dynamics develops smart food packging for product traceability and quality control.
Ponce De Leon Pharmaceuticals
Developer of a health formulation comprised of GRAS (Generally Regarded As Safe) components.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Metys Pharmaceuticals
Official Site Inspections
http://www.metys-pharma.ch
- Host name: antiqua.sui-inter.net
- IP address: 80.74.148.70
- Location: Neunkirch Switzerland
- Latitude: 47.6901
- Longitude: 8.4998
- Timezone: Europe/Zurich
- Postal: 8213

More informations about "Metys Pharmaceuticals"
metys-pharma.ch | About
Contact. Novaremed AG Elisabethenstrasse 18 4051 Basel, Switzerland. Phone: +41 61 5640297 E-mail: [email protected]See details»
Metys Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number +41794087972 Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy …See details»
Metys Pharmaceuticals AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Metys Pharmaceuticals AG of Basel, BASEL-STADT. Get the latest business insights from Dun & …See details»
Metys Pharmaceuticals AG :: Switzerland - OpenCorporates
Free and open company data on Switzerland company Metys Pharmaceuticals AG (company number 1137897), Elisabethenstrasse, 18, Basel, 4051See details»
Metys Pharmaceuticals AG - Basel, Schweiz - bionity.com
Metys Pharmaceuticals wurde 2013 von Dr. Michael Scherz, einem Medizinchemiker mit einer 25-jährigen Karriere in der Arzneimittelentwicklung und -entdeckung, gegründet. ... metys …See details»
Metys Pharmaceuticals - Company Profile - Tracxn
Feb 24, 2025 Metys Pharmaceuticals - Developer of drugs for chemotherapy-induced peripheral neuropathy. Acquired by Novaremed. Raised funding over 2 rounds from 2 investors. Founded …See details»
metys-pharma.ch | Impressum
Metys Pharmaceuticals AG, a wholly-owned subsidiary of Novaremed AG Elisabethenstrasse 18 4051 Basel. Webdesign & Programmierung JKweb, Webdesign Basel. Metys Pharmaceuticals …See details»
Metys Pharmaceuticals AG, Basel | business-monitor.ch
Metys Pharmaceuticals AG, aktiv in "Forschung und Entwicklung im Bereich Biotechnologie" - Handelsregistereintrag, Netzwerk, Branche, Entscheidungsträger und Kontakte, SHAB. ...See details»
Metys Pharmaceuticals Ag · Gerbergasse 30, Basel, BS 4001, CHE
Metys Pharmaceuticals Ag (SAM# GM4XS34LUTW1) is an entity registered with U.S. General Services Administration (GSA), System for Award Management (SAM). The registration date …See details»
Metys Pharmaceuticals AG:Company Profile & Technical Research ...
Metys Pharmaceuticals AG is a company that provides Chemotherapy-induced peripheral neuropathy, Dimiracetam, Medical equipment and more. Metys Pharmaceuticals AG is …See details»
Metys Pharmaceuticals AG - Drug pipelines, Patents, Clinical trials ...
Explore Metys Pharmaceuticals AG with its drug pipeline, therapeutic area, technology platform, 1 news, and 3 literature, Disease Domain:Nervous System Diseases, Technology …See details»
Metys Pharmaceuticals - Overview, News & Similar companies
View Metys Pharmaceuticals (www.metys-pharma.ch) location in Basel-City, Switzerland , revenue, industry and description. Find related and similar companies as well as employees …See details»
Metys Pharmaceuticals AG - Handelszeitung
Die Gesellschaft die Erforschung, die Entwicklung, die Herstellung und den Vertrieb von pharmazeutischen, biologischen, diagnostischen und anderen Produkten auf dem Gebiet der …See details»
Metys Pharmaceuticals AG - startup.ch
Metys Pharmaceuticals AG: Michael Scherz founded Metys Pharmaceuticals in April 2013 to re-start the clinical development of dimiracetam. The company is developing dimiracetam for …See details»
Metys Pharmaceuticals - VentureRadar
Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy-induced peripheral neuropathy, an uncomfortable and troubling side effect of several important cancer …See details»
Metys Pharmaceuticals AG - Basel, Switzerland - bionity.com
Metys-pharma.ch. Contact. Profile ... Metys Pharmaceuticals is developing dimiracetam for the prevention of chemotherapy-induced painful peripheral neuropathy. In the US alone, in a …See details»
Metys Pharmaceuticals - Craft
Metys Pharmaceuticals is a company that provides treatment for chemotherapy-induced peripheral neuropathy, a side effect of several cancer treatments. It develops MP-101, an …See details»
List of Pharmaceutical Companies in Switzerland - Page 3 of 4 ...
Website: www.merz.ch. Metys Pharmaceuticals AG. Address: Gerbergasse 30, 4001 Basel, Switzerland Fax: +41 61 568 40 70 Website: metys-pharma.ch. MSD International GmbH. …See details»
metys-pharma.ch | SMi Pain Therapeutics
Metys-pharma.ch. About. Contact; SMi Pain Therapeutics overview. London, UK, 14 May 2019. The SMi Pain Therapeutics Congress of 14-15 May 2019 is taking place under the co …See details»
HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma …
1 day ago How we use your personal data How we use your information depends on the product and service that you use and your relationship with us.See details»